Three simple things Australia should do to secure access to treatments, vaccines, tests and devices during the coronavirus crisis
- Written by Deborah Gleeson, Senior Lecturer in Public Health, La Trobe University
ShutterstockPatents and related intellectual property rights can present formidable barriers to procuring medicines, vaccines, diagnostic tests and medical devices.
They can cost lives, particularly during a public health emergency.
Two examples from the United States illustrate the point.
The US conglomerate 3M holds hundreds of patents on N95 face...